Buy & Sell Sirius XM Holdings Inc (SIRI) – Sirius XM Holdings Inc Price Today
Aura AI Summary
Key Stats
- $8.69BMarket Cap
- MediaSector
- -7.95%3M Drawdown
- $18.37BEnterprise Value
- 4.18%Dividend Yield
- 89 daysTypical Hold Time
Sirius XM Holdings Inc (SIRI) is currently valued at a market capitalization of $8.69B, with an enterprise value of $18.37B. Over the past 52 weeks, Sirius XM Holdings Inc has traded between a low of $19.92 and a high of $28.06, highlighting its annual price range. Over the past three months, Sirius XM Holdings Inc has recorded a drawdown of -7.95%, reflecting recent price volatility. Sirius XM Holdings Inc offers a dividend yield of 4.18%, with the most recent dividend of $0.27 paid on 11 May 26. On average, investors hold Sirius XM Holdings Inc for approximately 89 days, indicating typical investor behavior on the platform.
About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Most Recent News
Sitryx Therapeutics to present at major healthcare investor conferences in June 2026
Sitryx Therapeutics, a clinical-stage biopharmaceutical company focused on autoimmune and inflammatory diseases, announced its management will participate in three key investor conferences in June 2026: Jefferies Global Healthcare Conference in New Y...
Regeneron shares drop 10% after Phase 3 melanoma trial misses primary endpoint.
Regeneron Pharmaceuticals' stock fell over 10% following the Phase 3 trial results for their melanoma treatment combining fianlimab and cemiplimab. The trial did not achieve statistical significance for the primary endpoint of progression-free surviv...
Auddia highlights $29B AI infrastructure potential via LT350's GPU-powered parking lot data centers.
Auddia Inc. spotlighted the AI infrastructure opportunity of its LT350 subsidiary, referencing a $1.25 billion GPU cloud contract by SharonAI as a market benchmark. LT350's patented design uses parking lot airspace to deploy up to 960,000 GPUs, poten...
